International Immunology Advance Access originally published online on October 7, 2005
International Immunology 2005 17(11):1367-1378; doi:10.1093/intimm/dxh318
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review Article |
Regulation of the type I IFN induction: a current view
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan
Correspondence to: T. Taniguchi; E-mail: tada{at}m.u-tokyo.ac.jp
The type I IFN-
/ß gene family was identified about a quarter of a century ago as a prototype of many cytokine gene families, which led to the subsequent burst of studies on molecular mechanisms underlying cytokine gene expression and signaling. Although originally discovered for their activity to confer an antiviral state on cells, more evidence has recently been emerging regarding IFN-/ß actions on cell growth, differentiation and many immunoregulatory activities, which are of even greater fundamental biological significance. Indeed, much attention has recently been focused on the induction and function of the IFN-/ß system regulated by Toll-like receptors (TLRs), which are critical for linking the innate and adaptive immunities. The understanding of the regulatory mechanisms of IFN-/ß gene induction by TLRs and viruses is an emerging theme, for which much new insight has been gained over the past few years.
Keywords: antiviral immunity, host defense, interferon, IRF, plasmacytoid dendritic cell, Toll-like receptor
Transmitting editor: H. Kikutani
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Wu, E. Fossum, C. H. Joo, K.-S. Inn, Y. C. Shin, E. Johannsen, L. M. Hutt-Fletcher, J. Hass, and J. U. Jung Epstein-Barr Virus LF2: an Antagonist to Type I Interferon J. Virol., January 15, 2009; 83(2): 1140 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Richez, K. Yasuda, A. A. Watkins, S. Akira, R. Lafyatis, J. M. van Seventer, and I. R. Rifkin TLR4 Ligands Induce IFN-{alpha} Production by Mouse Conventional Dendritic Cells and Human Monocytes after IFN-{beta} Priming J. Immunol., January 15, 2009; 182(2): 820 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Osterloh, A. Veit, A. Gessner, B. Fleischer, and M. Breloer Hsp60-mediated T cell stimulation is independent of TLR4 and IL-12 Int. Immunol., March 1, 2008; 20(3): 433 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ha, J.-H. Lee, H.-N. Kim, H. B. Kwak, H.-M. Kim, S. E. Lee, J. H. Rhee, H.-H. Kim, and Z. H. Lee Stimulation by TLR5 Modulates Osteoclast Differentiation through STAT1/IFN-{beta} J. Immunol., February 1, 2008; 180(3): 1382 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jung, H. Kato, Y. Kumagai, H. Kumar, T. Kawai, O. Takeuchi, and S. Akira Lymphocytoid Choriomeningitis Virus Activates Plasmacytoid Dendritic Cells and Induces a Cytotoxic T-Cell Response via MyD88 J. Virol., January 1, 2008; 82(1): 196 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-K. Kim, J.-S. Lee, S.-Y. Oh, X. Jin, Y.-J. Choi, T.-H. Lee, E. h. Lee, Y.-K. Choi, S. You, Y. G. Chung, et al. Direct Transcriptional Activation of Promyelocytic Leukemia Protein by IFN Regulatory Factor 3 Induces the p53-Dependent Growth Inhibition of Cancer Cells Cancer Res., December 1, 2007; 67(23): 11133 - 11140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. I. Osterlund, T. E. Pietila, V. Veckman, S. V. Kotenko, and I. Julkunen IFN Regulatory Factor Family Members Differentially Regulate the Expression of Type III IFN (IFN-{lambda}) Genes J. Immunol., September 15, 2007; 179(6): 3434 - 3442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Marshall, D. S. Heeke, M. L. Gesner, B. Livingston, and G. Van Nest Negative regulation of TLR9-mediated IFN-{alpha} induction by a small-molecule, synthetic TLR7 ligand J. Leukoc. Biol., September 1, 2007; 82(3): 497 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. J. Roberts, N. Goutagny, P.-Y. Perera, H. Kato, H. Kumar, T. Kawai, S. Akira, R. Savan, D. van Echo, K. A. Fitzgerald, et al. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis J. Exp. Med., July 9, 2007; 204(7): 1559 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Sariol, J. L. Munoz-Jordan, K. Abel, L. C. Rosado, P. Pantoja, L. Giavedoni, I. V. Rodriguez, L. J. White, M. Martinez, T. Arana, et al. Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1 Clin. Vaccine Immunol., June 1, 2007; 14(6): 756 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jaworska, A. Gravel, K. Fink, N. Grandvaux, and L. Flamand Inhibition of Transcription of the Beta Interferon Gene by the Human Herpesvirus 6 Immediate-Early 1 Protein J. Virol., June 1, 2007; 81(11): 5737 - 5748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Graham, C. Kyogoku, S. Sigurdsson, I. A. Vlasova, L. R. L. Davies, E. C. Baechler, R. M. Plenge, T. Koeuth, W. A. Ortmann, G. Hom, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus PNAS, April 17, 2007; 104(16): 6758 - 6763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nociari, O. Ocheretina, J. W. Schoggins, and E. Falck-Pedersen Sensing Infection by Adenovirus: Toll-Like Receptor-Independent Viral DNA Recognition Signals Activation of the Interferon Regulatory Factor 3 Master Regulator J. Virol., April 15, 2007; 81(8): 4145 - 4157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Aksoy, V. Albarani, M. Nguyen, J.-F. Laes, J.-L. Ruelle, D. De Wit, F. Willems, M. Goldman, and S. Goriely Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells Blood, April 1, 2007; 109(7): 2887 - 2893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Onoguchi, M. Yoneyama, A. Takemura, S. Akira, T. Taniguchi, H. Namiki, and T. Fujita Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism J. Biol. Chem., March 9, 2007; 282(10): 7576 - 7581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ramsauer, M. Farlik, G. Zupkovitz, C. Seiser, A. Kroger, H. Hauser, and T. Decker Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-{gamma}-inducible gbp2 gene PNAS, February 20, 2007; 104(8): 2849 - 2854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gourzi, T. Leonova, and F. N. Papavasiliou Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-{kappa}B J. Exp. Med., February 19, 2007; 204(2): 259 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Osterloh, U. Kalinke, S. Weiss, B. Fleischer, and M. Breloer Synergistic and Differential Modulation of Immune Responses by Hsp60 and Lipopolysaccharide J. Biol. Chem., February 16, 2007; 282(7): 4669 - 4680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Balachandran, T. Venkataraman, P. B. Fisher, and G. N. Barber Fas-Associated Death Domain-Containing Protein-Mediated Antiviral Innate Immune Signaling Involves the Regulation of Irf7 J. Immunol., February 15, 2007; 178(4): 2429 - 2439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Crandall, D. M. Dunn, Y. Ma, R. M. Wooten, J. F. Zachary, J. H. Weis, R. B. Weiss, and J. J. Weis Gene Expression Profiling Reveals Unique Pathways Associated with Differential Severity of Lyme Arthritis J. Immunol., December 1, 2006; 177(11): 7930 - 7942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Opitz, M. Vinzing, V. van Laak, B. Schmeck, G. Heine, S. Gunther, R. Preissner, H. Slevogt, P. D. N'Guessan, J. Eitel, et al. Legionella pneumophila Induces IFNbeta in Lung Epithelial Cells via IPS-1 and IRF3, Which Also Control Bacterial Replication J. Biol. Chem., November 24, 2006; 281(47): 36173 - 36179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Perry and T. Compton Kaposi's Sarcoma-Associated Herpesvirus Virions Inhibit Interferon Responses Induced by Envelope Glycoprotein gpK8.1 J. Virol., November 15, 2006; 80(22): 11105 - 11114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kumar, T. Kawai, H. Kato, S. Sato, K. Takahashi, C. Coban, M. Yamamoto, S. Uematsu, K. J. Ishii, O. Takeuchi, et al. Essential role of IPS-1 in innate immune responses against RNA viruses J. Exp. Med., July 10, 2006; 203(7): 1795 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Cao, D. B. Rosen, T. Ito, L. Bover, M. Bao, G. Watanabe, Z. Yao, L. Zhang, L. L. Lanier, and Y.-J. Liu Plasmacytoid dendritic cell-specific receptor ILT7-Fc{varepsilon}RI{gamma} inhibits Toll-like receptor-induced interferon production J. Exp. Med., June 12, 2006; 203(6): 1399 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gitlin, W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R. A. Flavell, M. S. Diamond, and M. Colonna Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus PNAS, May 30, 2006; 103(22): 8459 - 8464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Delhaye, S. Paul, G. Blakqori, M. Minet, F. Weber, P. Staeheli, and T. Michiels Neurons produce type I interferon during viral encephalitis PNAS, May 16, 2006; 103(20): 7835 - 7840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Szomolanyi-Tsuda, X. Liang, R. M. Welsh, E. A. Kurt-Jones, and R. W. Finberg Role for TLR2 in NK Cell-Mediated Control of Murine Cytomegalovirus In Vivo J. Virol., May 1, 2006; 80(9): 4286 - 4291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Seya, T. Akazawa, T. Tsujita, and M. Matsumoto Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 31 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sasai, M. Matsumoto, and T. Seya The Kinase Complex Responsible for IRF-3-Mediated IFN-{beta} Production in Myeloid Dendritic Cells (mDC) J. Biochem., February 1, 2006; 139(2): 171 - 175. [Abstract] [Full Text] [PDF]
|
|